Skip to content
healthcare.dev

Cevimeline Hydrochloride

NDC 0054-0334, Cevimeline Hydrochloride, capsule, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0334
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEVIMELINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]

Package NDCNDC-11Package
0054-0334-2500054033425100 CAPSULE in 1 BOTTLE (0054-0334-25)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1167360c-7e0f-4619-9d1a-ad4ee56cab71
  • NADAC price for package 00054033425

    GET /v1/drugs/nadac/00054033425

Use it

Look up 0054-0334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.